NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/30/2024
Back to search
Official data from USPTO
NEELYX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/30/2024
Trademark type
Word
Nice classes
42, 44
Filing date
04/15/2022
Registration date
01/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2024
Last transaction
01/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/15/2021
First use in commerce
02/01/2021
Drawing code
4
Owner type
03
Owner location
Wood Dale, IL, US
Examiner
PARKER, JUSTINE D
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Neelyx Labs Inc
Representatives
Neelyx Labs Inc
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Basic and clinical research in the field of respiratory science and medicine; Biochemical research; Biochemical research and analysis; Biochemical research and development; Biomedical research services; Computer diagnostic services; Consultancy pertaining to pharmacology; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; Development of new technology for others in the field of molecular testing and molecular diagnostics; Medical testing for diagnostic purposes featuring laboratory clinical and molecular testing in the field of epidemiology; Diagnostic services in the field of medical instruments for intake and processing reports for laboratory clinical and molecular testing; Diagnostic services in the field of medical instruments for researchdevelopment and clinical testing; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Engineering servicesengineering in the field of molecular diagnostics; Genetic testing for scientific research purposes; Genome amplification; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of molecular diagnostics; Medical and scientific researchconducting clinical trials for others; Medical laboratory services; Medical research; Medical research in the field of epidemiology; Medical research services; Pharmaceutical research services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research on the subject of pharmaceuticals; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research consulting; Scientific research in the field of genetics and genetic engineering; Scientific study and research in the field(s) of molecular testing and molecular diagnostics; Structural and functional analysis of genomes
Class 44
Antibody testing for medical diagnostic or treatment purposes; Consulting services in the fields of diagnostic medical testing and nutrition; Genetic testing of animals for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testingmonitoring and reporting services; Medical testing for diagnostic or treatment purposes; Medical testing of urinebloodhair follicles and breath; Medical testing services relating to the diagnosis and treatment of disease; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Veterinary specialty services providing advanced medicaldiagnostic or surgical services for animals; Virus testing for medical diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/14/2023
PUBO
PUBLISHED FOR OPPOSITION
11/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/31/2023
ALIE
ASSIGNED TO LIE
08/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/18/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/18/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/18/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/18/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/02/2023
GNRT
NON-FINAL ACTION E-MAILED
02/02/2023
CNRT
NON-FINAL ACTION WRITTEN
02/02/2023
DOCK
ASSIGNED TO EXAMINER
02/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/20/2022
NWAP
NEW APPLICATION ENTERED
04/19/2022
Continuous trademark protection
Get notified about every new filing that threatens NEELYX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.